This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Forbes
forbes.com
did:plc:2w45zyhuklwihpdc7oj3mi63
Hims and Hears walked back on its plans to launch a cheaper compounded version of the Wegovy pill after facing legal threats from Novo Nordisk and U.S. health authorities.
http://www.forbes.com/sites/siladityaray/2026/02/09/hims--hers-falls-14-after-it-pulls-pulls-copycat-wegovy-pill-novo-nordisk-up-8/?utm_campaign=forbes&utm_medium=social&utm_source=bluesky
2026-02-09T10:30:08.154Z